[Nephrology 2010].
Zidek
W
W
Med. Klinik IV, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin. walter.zidek@charite.de
D058186:Acute Kidney Injury / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D001324:Autoantigens / Q000097:blood; D000068256:Darbepoetin alfa; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D008181:Lupus Nephritis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D017582:Renal Replacement Therapy
D001324:Autoantigens; D006397:Hematinics; D007166:Immunosuppressive Agents; D004921:Erythropoietin; D000068256:Darbepoetin alfa